EP Patent
EP3656403B1 — Preparation process of psma binding ligand-linker conjugates
Assigned to Purdue Research Foundation · Expires 2022-05-11 · 4y expired
What this patent protects
Patent listed against lutetium-lu-177-vipivotide-tetraxetan.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.